GILD CIK: 882095

Gilead Sciences Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
11.4
FY22:
9.07
FY23:
8.01
FY24:
10.8
FY25:
10.0
Change from FY21 to FY25
billions USD
FY21:
−3.13
FY22:
−2.47
FY23:
−2.27
FY24:
−3.45
FY25:
−4.79
Change from FY21 to FY25
billions USD
FY21:
−8.88
FY22:
−6.47
FY23:
−5.13
FY24:
−3.43
FY25:
−7.75
billions USD
FY21:
−0.66
FY22:
0.07
FY23:
0.67
FY24:
3.91
FY25:
−2.43
(positive)
Change from FY21 to FY25
billions USD
FY21:
10.8
FY22:
8.34
FY23:
7.42
FY24:
10.3
FY25:
9.46

All amounts in billions USD Data source:SEC EDGAR